Yeast's vacuole a privileged niche that protects intracellular bacteria against antibiotics
- PMID: 40063265
- DOI: 10.1007/s00203-025-04281-8
Yeast's vacuole a privileged niche that protects intracellular bacteria against antibiotics
Abstract
Detection of Helicobacter pylori, Staphylococcus, Nocardia and Cyanobacteria inside the yeast Candida tropicalis raised the question whether treating yeast with antibiotics mix (ABM) eliminates intracellular bacteria. Live/Dead staining showed occurrence of viable bacteria inside the vacuole of C. tropicalis. Amplification of bacterial 16S rRNA genes from yeast DNA with the size of 521, 750, 606 and 450 bp were similar to those from control H. pylori, Staphylococcus, Nocardia and Cyanobacteria, respectively. To eliminate intracellular bacteria yeast cultures in yeast-glucose (YG) broth were treated with 32-1024 μg/mL of ABM (amoxicillin, ciprofloxacin, rifampin and metronidazole) for up to 24 h. Viability of treated yeast cells and their intracellular bacteria was assessed by colony count, Live/Dead staining and detection of bacterial 16S rRNA genes. Colony count of C. tropicalis exposed to 32-256 μg/mL of ABM (4.39-9.63) or 512-1024 μg/mL (9.67-9.77) were similar to their respected controls (p > 0.05). Amplification of similar bacterial genes from treated yeasts and controls confirmed persistent occurrence of intracellular bacteria. Micrographs of yeasts treated with 32-256 μg/mL of ABM showed intact yeasts and intracellular bacteria, however those treated with 512 and 1024 μg/mL showed occurrence of < 10% and > 10% yellow damaged yeasts, respectively that accumulated yellow rifampin. Fluorescence microscopy showed that both intact and damaged yeasts carried live bacteria inside their vacuole. Culture of treated yeasts on YG agar produced colonies with totally intact yeasts and intracellular bacteria. Yeast extruded antibiotics and reduced their effective concentration for killing intracellular bacteria. Establishment of bacteria inside the fungal vacuole cannot be disrupted with antibiotics.
Keywords: Antibiotics mix (ABM); Intracellular bacteria; Protective niche; Yeast’s vacuole.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: There is no conflict of interest to declare.
Similar articles
-
Sequestration inside the yeast vacuole may enhance Helicobacter pylori survival against stressful condition.Infect Genet Evol. 2019 Apr;69:127-133. doi: 10.1016/j.meegid.2019.01.029. Epub 2019 Jan 23. Infect Genet Evol. 2019. PMID: 30682548
-
Candida albicans Release Intracellular Bacteria When Treated With Amphotericin B.Arch Iran Med. 2018 May 1;21(5):191-198. Arch Iran Med. 2018. PMID: 29738262
-
Sugar-Rich Foods Carry Osmotolerant Yeasts with Intracellular Helicobacter Pylori and Staphylococcus spp.Middle East J Dig Dis. 2020 Jul;12(3):182-193. doi: 10.34172/mejdd.2020.181. Middle East J Dig Dis. 2020. PMID: 33062224 Free PMC article.
-
Vacuoles of Candida yeast as a specialized niche for Helicobacter pylori.World J Gastroenterol. 2014 May 14;20(18):5263-73. doi: 10.3748/wjg.v20.i18.5263. World J Gastroenterol. 2014. PMID: 24833856 Free PMC article. Review.
-
Localization of H.pylori within the vacuole of Candida yeast by direct immunofluorescence technique.Arch Iran Med. 2013 Dec;16(12):705-10. Arch Iran Med. 2013. PMID: 24329143
References
-
- Adams DG, Duggan PS (2008) Cyanobacteria–bryophyte symbioses. J Exp Bot 59(5):1047–1058
-
- Anandan R, Dharumadurai D, Manogaran GP (2016) An introduction to actinobacteria. IntechOpen, london, In Actinobacteria-basics and biotechnological applications
-
- Armstrong J (2010) Yeast vacuoles: more than a model lysosome. Trends Cell Biol 20(10):580–585
-
- Aufschnaiter A, Büttner S (2019) The vacuolar shapes of ageing: From function to morphology. Biochim et Biophys Acta (BBA)- Molecular Cell Res 1866(5):957–970
-
- Barcia-Macay M, Seral C, Mingeot-Leclercq M-P, Tulkens PM, Van Bambeke F (2006) Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob Agents Chemother 50(3):841–851 - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical